Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

NCT00001313 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT00001313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Completed
Start date
May 10, 1992
Completion date
January 6, 2009
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary disease, diabetes and heart failure, dilated cardiomyopathy, heart failure, peripheral artery disease, pulmonary hypertension, renal artery stenosis